Brief: Resapp Health Entered Into Further Amended And Restated Scheme Implementation Deed With Pfizer
03/08/2022 02:34
Aug 3 (Reuters) - Resapp Health Ltd RAP.AX :
* ENTERED INTO A FURTHER AMENDED AND RESTATED SCHEME
IMPLEMENTATION DEED WITH PFIZER
* DEED TO INCREASE PROPOSED CONSIDERATION TO A$0.208 PER
RESAPP
SHARE
Source text for Eikon: ID:nASX91V02s
Further company coverage: RAP.AX
Recent news on Raptor Metals
See all newsBrief: Raptor Metals Seeks Trading Halt
Australian Gold and Copper climbs on Eastern Metal's project acquisition
Brief: Eastern Metals Enters Bid Implementation Agreement To Acquire Raptor Resources
Brief: Eastern Metals Revises Deal Structure For Acquiring RRL Via Takeover
Brief: Eastern Metals Announces Up To A$4.3 Mln Capital Raising